Skip to main content
Signal8

Odysseas Kostas D

SEC insider (Form 3/4/5 filer). CIK 0001483080. Director at AMARIN CORP PLC\UK (AMRN) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 18, 2026. Located in GREENWICH, CT.

Companies Odysseas Kostas D has filed insider reports for

  • AMARIN CORP PLC\UK (AMRN): Director
  • Armata Pharmaceuticals, Inc. (ARMP): Director
Odysseas Kostas D profile photo

Odysseas Kostas D

CIK: 0001483080

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AMARIN CORP PLC\UK logo
AMRN

AMARIN CORP PLC\UK

Director
Armata Pharmaceuticals, Inc. logo
ARMP

Armata Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • AMARIN CORP PLC\UK logo
    AMRN

    AMARIN CORP PLC\UK

    Apr 18, 2026
    Exercise
    Direct
    838 shares-
  • AMARIN CORP PLC\UK logo
    AMRN

    AMARIN CORP PLC\UK

    Apr 18, 2026
    Tax Payment
    Direct
    403 shares at avg. $14.98$6K
  • Armata Pharmaceuticals, Inc. logo
    ARMP

    Armata Pharmaceuticals, Inc.

    Mar 9, 2026
    Award

    Stock Options (Right to Buy)

    Direct
    25.6K shares-
  • AMARIN CORP PLC\UK logo
    AMRN

    AMARIN CORP PLC\UK

    Apr 18, 2025
    Exercise
    Direct
    838 shares-
  • AMARIN CORP PLC\UK logo
    AMRN

    AMARIN CORP PLC\UK

    Apr 18, 2025
    Tax Payment
    Direct
    437 shares at avg. $9.11$4K
  • Armata Pharmaceuticals, Inc. logo
    ARMP

    Armata Pharmaceuticals, Inc.

    Feb 5, 2025
    Award

    Stock Options (Right to Buy)

    Direct
    54.3K shares-

1-6 of 6